These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3788960)

  • 21. Elevated plasma levels of fibrinopeptide A during sickle cell anemia pain crisis--evidence for intravascular coagulation.
    Leichtman DA; Brewer GJ
    Am J Hematol; 1978; 5(3):183-90. PubMed ID: 752258
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolution of laboratory parameters during sickle cell painful crisis: evidence compatible with dense red cell sequestration without thrombosis.
    Billett HH; Nagel RL; Fabry ME
    Am J Med Sci; 1988 Nov; 296(5):293-8. PubMed ID: 2973751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
    Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
    Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of coagulation and fibrinolytic systems following stroke.
    Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
    Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial plasma fibrinogen changes accompanying sickle cell pain crisis.
    Famodu AA; Adedeji MO; Reid HL
    Clin Lab Haematol; 1990; 12(1):43-7. PubMed ID: 2344715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.
    Richardson SG; Breeze GR; Stuart J
    J Clin Pathol; 1976 Oct; 29(10):890-3. PubMed ID: 977763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
    Wojciechowski J; Olausson M; Korsan-Bengtsen K
    Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procoagulant activity in patients with sickle cell trait.
    Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemostasis alterations in sickle cell syndrome].
    Higuera D; Bravo M; Guerrero B
    Invest Clin; 2014 Jun; 55(2):173-84. PubMed ID: 24974633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Falsely low activated clotting time measured in a patient with sickle cell trait.
    Crook R; Wheeler K
    Perfusion; 2019 May; 34(4):334-336. PubMed ID: 30628549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica.
    Leslie J; Langler D; Serjeant GR; Serjeant BE; Desai P; Gordon YB
    Br J Haematol; 1975 Jun; 30(2):159-66. PubMed ID: 1201207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood proteins C and S in sickle cell disease.
    el-Hazmi MA; Warsy AS; Bahakim H
    Acta Haematol; 1993; 90(3):114-9. PubMed ID: 8291368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C.
    Bezeaud A; Venisse L; Helley D; Trichet C; Girot R; Guillin MC
    Br J Haematol; 2002 May; 117(2):409-13. PubMed ID: 11972526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
    Dieye TN; Ndiaye O; Ndiaye AB; Thiam D; Fall-Seck K; Diop S; Diop BM; Fall M; Diakhaté L
    Dakar Med; 1999; 44(2):175-9. PubMed ID: 11957280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet regulatory prostanoids and platelet release products in sickle cell disease.
    Longenecker GL; Beyers BJ; Mankad VN
    Am J Hematol; 1992 May; 40(1):12-9. PubMed ID: 1533087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
    Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
    Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation fibrinolysis in sickle-cell disease.
    Gordon PA; Breeze GR; Mann JR; Stuart J
    J Clin Pathol; 1974 Jun; 27(6):485-9. PubMed ID: 4412492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukocyte counts in children with sickle cell disease. Comparative values in the steady state, vaso-occlusive crisis, and bacterial infection.
    Buchanan GR; Glader BE
    Am J Dis Child; 1978 Apr; 132(4):396-8. PubMed ID: 645659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulation changes in sickle cell disease in early childhood.
    Babiker MA; Ashong EF; Bahakim H; Gader AM
    Acta Haematol; 1987; 77(3):156-60. PubMed ID: 3113156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red cell distribution width in sickle cell disease.
    Webster P; Castro O
    Ann Clin Lab Sci; 1986; 16(4):274-7. PubMed ID: 3740796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.